Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2023-03-02 00:00:00 ET · period of report 2023-02-28 · accession 0001209191-23-014869 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-02 | 2023-03-01 | KPTI | Mitchener Stephen | SVP, Chief Business Off | S - Sale | $3.03 | -6,357 | 128.3K | -5% | -$19.3K | |
| 2023-03-02 | 2023-02-28 | KPTI | Mitchener Stephen | SVP, Chief Business Off | A - Grant | $0.00 | +60.0K | 134.7K | +80% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | S | D | 6,357 | $3.03 | 128,313 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-28 | A | A | 60,000 | $0.00 | 134,670 | D | — | — | (F1) Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in three equal annual installments beginning February 28, 2024. (F2) Includes 2,147 shares and 1,977 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on April 30, 2022 and October 31, 2022, respectively. |